Sara Amaral

Ms. Sara Amaral

Faculty of Engineering of the University of Porto
+1
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in Carbon
Verified
Journal Article
Closed access
Sara AmaralSara Amaral
Sara Amaral
Raquel Costa-AlmeidaRaquel Costa-Almeida
Raquel Costa-Almeida
IGInês C. Gonçalves
Inês C. Gonçalves
FMFernão D. Magalhães
Fernão D. Magalhães
Artur PintoArtur Pinto
Artur Pinto

25 May 2021 in Materials
Verified
Journal Article
Open access
PDF file
FSFilipa Silva
Filipa Silva
Raquel Costa-AlmeidaRaquel Costa-Almeida
Raquel Costa-Almeida
LTLicínia Timochenco
Licínia Timochenco
Sara AmaralSara Amaral
Sara Amaral
SPSoraia Pinto
Soraia Pinto
Artur PintoArtur Pinto
Artur Pinto
Nanostructured carriers have been widely used in pharmaceutical formulations for dermatological treatment. They offer targeted drug delivery, sustained release, improved biostability, and low toxicity, usually presenting advantages over conventional formulations. Due to its large surface area, small size and photothermal properties, graphene oxide (GO) has the potential to be used for such applications. Nanographene oxide (GOn) presented average sizes of 197.6 ± 11.8 nm, and a surface charge of −39.4 ± 1.8 mV, being stable in water for over 6 months. 55.5% of the mass of GOn dispersion (at a concentration of 1000 µg mL−1) permeated the skin after 6 h of exposure. GOn dispersions have been shown to absorb near-infrared radiation, reaching temperatures up to 45.7 °C, within mild the photothermal therapy temperature range. Furthermore, GOn in amounts superior to those which could permeate the skin were shown not to affect human skin fibroblasts (HFF-1) morphology or viability, after 24 h of incubation. Due to its large size, no skin permeation was observed for graphite particles in aqueous dispersions stabilized with Pluronic P-123 (Gt–P-123). Altogether, for the first time, Gon’s potential as a topic administration agent and for delivery of photothermal therapy has been demonstrated.

22 March 2021 in Preprints.org
Verified
Preprint
Open access
FSFilipa A. L. S. Silva
Filipa A. L. S. Silva
Raquel Costa-AlmeidaRaquel Costa-Almeida
Raquel Costa-Almeida
LTLicínia Timochenco
Licínia Timochenco
Sara AmaralSara Amaral
Sara Amaral
SPSoraia Pinto
Soraia Pinto
Artur PintoArtur Pinto
Artur Pinto
Nanostructured carriers have been widely used in pharmaceutical formulations for dermatological treatment. They offer targeted drug delivery, sustained release, improved biostability, and low toxicity, usually presenting advantages over conventional formulations. Due to its large surface area, small size and photothermal properties, graphene oxide (GO) has the potential to be used for such applications. Nanographene oxide (GOn) presented average sizes of 197.6 ± 11.8 nm, and a surface charge of -39.4 ± 1.8 mV, being stable in water for over 6 months. 55.5 % of the mass of GOn dispersion (at a concentration of 1 mg mL-1) permeated the skin after 6 h of exposure. GOn dispersions have been shown to absorb near-infrared radiation, reaching temperatures up to 45.7 °C, within mild photothermal therapy temperature range. Furthermore, GOn in amounts superior to those which could permeate the skin were shown not to affect human skin fibroblasts (HFF-1) morphology or viability, after 24 h of incubation. Due to its large size, no skin permeation was observed for graphite particles in aqueous dispersions stabilized with Pluronic P-123 (Gt-P-123). Altogether, for the first time, GOn potential as a topic administration agent and for delivery of photothermal therapy has been demonstrated.